Skip to main contentDefendant WinUnresolvableUnresolvableUnresolvable
Blue Cross & Blue Shield v. Mylan Laboratories, Inc.
D.C. CircuitJanuary 18, 2011No. Nos. 08-5044, 08-5045Cited 3 times
Case Details
- Judge(s)
- Randolph, Sentelle, Williams
- Status
- Published
- Procedural Posture
- appeal
- Circuit
- DC Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
The appellate court vacated the $76.8 million jury verdict and remanded the case due to lack of diversity jurisdiction caused by the presence of non-diverse self-funded customers as real parties in interest, though allowing the district court to consider dismissing the non-diverse parties under Rule 21.
Similar Rulings
Astrazeneca AB v. Mylan Laboratories, Inc.
Federal CircuitJun 2008
Astrazeneca AB v. Mylan Laboratories, Inc.
Federal CircuitFeb 2008
Astrazeneca AB v. Mylan Laboratories, Inc.
Federal CircuitJan 2008
Center for Biological Diversity v. Lee Zeldin
D.C. CircuitMar 2026
DOJ
D.C. CircuitMar 2026
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.